Benzopyran selective estrogen receptor modulators (SERMs): Pharmacological effects and structural correlation with raloxifene
✍ Scribed by Timothy A. Grese; James P. Sluka; Henry U. Bryant; Harlan W. Cole; John R. Kim; David E. Magee; Ellen R. Rowley; Masahiko Sato
- Publisher
- Elsevier Science
- Year
- 1996
- Tongue
- English
- Weight
- 314 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0960-894X
No coin nor oath required. For personal study only.
✦ Synopsis
Several 2,3-diarylbenzopyrans have been evaluated in an ovariectomized rat model and found to exhibit tissue selective estrogen agonist activity on bone and serum lipid parameters. A structural model that accounts for the pharmacological similarity of these benzopyrans and the benzothiophene SERM, raloxifene, is proposed.
📜 SIMILAR VOLUMES
## Abstract We studied the beneficial effects of dietary consumption of n‐3 polyunsaturated fatty acids (PUFA) and two selective estrogen receptor modulator (SERM) derivatives (SERM‐I and SERM‐II) and their combined effect on serum lipids, skin dermis and adipose layers, bone marrow adipogenesis, a